<DOC>
	<DOCNO>NCT01254955</DOCNO>
	<brief_summary>Organ transplant patient staff member Transplant Institute receive pandemic H1N1 influenza vaccine ( Pandemrix ) specific antibody production measure haemagglutination inhibition accord clinical guideline policy , respectively . This study retrospectively assess immune response vaccination .</brief_summary>
	<brief_title>Antibody Production Following H1N1 Influenza Vaccination Organ Transplant Patients</brief_title>
	<detailed_description>A total 100 organ transplant patient 36 healthy control include study . All individual vaccinate October November 2009 receive 2 dos Pandemrix . Serum sample collect baseline vaccination 1 month first second vaccination . Individual hemagglutination-inhibiting serum antibody titer measured.Frequency &gt; 4 -fold increase antibody titer seroconversion non-protective prevaccination titer protective postvaccination titer record . Adverse event report .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Cohort number 1 : Organ transplant patient vaccinate serum sample drawn baseline . Cohort number 2 : Staff member vaccinate serum sample drawn baseline . Cohort number 1 : Organ transplant patient vaccinate serum sample drawn baseline . Cohort number 2 : Staff member vaccinate serum sample drawn baseline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>2009 H1N1 influenza vaccine , organ transplant patient</keyword>
</DOC>